Citius Oncology, Inc. ("Citius Oncology") (Nasdaq: CTOR), the oncology-focused subsidiary of Citius Pharmaceuticals, Inc.

The other day we saw a trademark filing for “Trump Mobile,” and turns out it was the real deal as it has been officially announced.

Arkay Beverages, the global pioneer in alcohol-free spirits, is officially opening its latest investment round, seeking to raise $150 million USD at a $1.5 billion valuation. This funding will acceler ...

Authored by 17 experts across healthcare, academia and technology, BRIDGE offers an open framework for turning AI ideas into real-world clinical s ...

The flash flooding in Ohio County has disrupted several blood drives and made it difficult to collect live-saving blood donations, but the Red Cross is asking people to make an appointment to ...

LONDON (Reuters) -A U.N. push for investment to protect the world's oceans yielded around $10 billion in deals at a ...

The Space Traffic Management Market is projected to grow from USD 15.9 billion in 2025 to USD 44.9 billion by 2034, driven by ...

FuelPositive Corp. (TSXV: NHHH) (OTCQB: NHHHF) is pleased to announce substantial progress in the final certification and ...